Genetic Technologies
GENE
#10586
Rank
C$5.15 M
Marketcap
C$1.06
Share price
0.00%
Change (1 day)
-69.36%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : C$0.81 Million

According to Genetic Technologies's latest financial reports the company's total debt is C$0.81 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30C$0.8 M71.56%
2023-06-30C$0.46 M-19.23%
2022-06-30C$0.57 M204.22%
2021-06-30C$0.18 M-57.73%
2020-06-30C$0.44 M
2019-06-30N/A
2015-06-30C$0.02 M-99.05%
2014-06-30C$2.51 M
2013-06-30N/A-100%
2012-06-30C$0.01 M-73.54%
2011-06-30C$0.06 M-79.48%
2010-06-30C$0.34 M-1.48%
2009-06-30C$0.34 M18.87%
2008-06-30C$0.29 M-38.11%
2007-06-30C$0.47 M-66.12%
2006-06-30C$1.38 M-28.24%
2005-06-30C$1.93 M202.1%
2004-06-30C$0.64 M2.12%
2003-06-30C$0.62 M
2002-06-30N/A-100%
2001-06-30C$0.09 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
C$54.72 B 6,723,597.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$9.14 B 1,124,072.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$27.36 B 3,362,346.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$9.06 B 1,114,000.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$4.09 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
C$1.10 B 135,266.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C$0.29 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$0.76 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA